glp-1 san francisco Are weight loss compounds safe? Not from this telehealth startup and its former supplier, whistleblowers say. @nbcbayarea #weinvestigate , #glp1community #glp1 #weightlossjourney GLP-1 obesity drugs may boost

Meanwhile, Connecticut has decided to maintain coverage of weight-loss drugs for state employees, but to require beneficiaries to try online weight-loss counseling before they can get a prescription

10.3390/molecules28247949 125 McCombeP

Phase 1b/2a Subcutaneous Formulation (Obesity) Published: The Lancet, June 2025 Participants: 125 adults with overweight or obesity (BMI 27.039.9), aged 1855 Duration: Up to 36 weeks Dosing: Once-weekly subcutaneous amycretin, up to 60 mg Results: - Up to 22% absolute weight loss at 36 weeks (highest dose group) - Placebo-adjusted difference: approximately 24% - No weight-loss plateau observed at study end Safety: 81% of the 89 participants who reported a TEAE had gastrointestinal events

Additionally, use of this product improves skin hydration and cellular repair, contributing to a more radiant and rejuvenated complexion